Osaka, Japan

Ritsuki Masuo

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Takatsuki, JP (2012)
  • Osaka, JP (2020)

Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ritsuki Masuo: Innovator in Pharmaceutical Compounds

Introduction

Ritsuki Masuo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health conditions. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Masuo's latest patents include a nitrogen-containing heterocyclic amide compound and its pharmaceutical use. This invention provides a compound with PDHK inhibitory activity, which is useful for treating or preventing diabetes, insulin resistance syndrome, metabolic syndrome, and several other serious health issues. His second patent involves indole compounds that serve as agents for treating inflammatory diseases, allergic diseases, autoimmune diseases, and transplant rejection.

Career Highlights

Ritsuki Masuo is currently associated with Japan Tobacco Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments for complex health conditions.

Collaborations

Masuo has collaborated with notable colleagues, including Teruhiko Inoue and Tetsudo Kaya, enhancing the scope and impact of his research.

Conclusion

Ritsuki Masuo's contributions to pharmaceutical innovations demonstrate his dedication to improving health outcomes through scientific advancements. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…